MenQuadfi

Registered for use in people aged ≥12 months

MenACWY-TT – quadrivalent meningococcal (serogroups A, C, W, Y)-tetanus toxoid conjugate vaccine

Clear, colourless, sterile, preservative-free solution

Each 0.5 mL dose of vaccine contains:

• 10 µg meningococcal polysaccharide serogroup A
• 10 µg meningococcal polysaccharide serogroup C
• 10 µg meningococcal polysaccharide serogroup W
• 10 µg meningococcal polysaccharide serogroup Y
• Each of the four polysaccharides is conjugated to tetanus toxoid (approximately 55 µg/dose)

For Product Information and Consumer Medicine Information about MenQuadfi visit the Therapeutic Goods Administration website.